Parameter | N | Median | Range |
---|---|---|---|
Age (years) | |||
Whole collective | 167 | 47 | 16-87 |
Benign diseases | 104 | 48 | 19-86 |
BOT without InvImp | 48 | 44 | 16-83 |
BOT with InvImp | 15 | 55 | 25-87 |
Preoperative HE4 (pmol/L) | |||
Benign diseases | 104 | 50 | 20-1410 |
BOT without InvImp | 48 | 52 | 29-2135 |
BOT with InvImp | 15 | 74 | 35-461 |
Preoperative CA125 (IU/ml) | |||
Benign diseases | 104 | 21 | 5-334 |
Non-invasive BOT | 48 | 25 | 3-725 |
Invasive BOT | 15 | 63 | 12-259 |
Histological type of BOT | N (without InvImp) | N (with InvImp) | N (total) |
Serous | 29 | 10 | 39 |
Mucinous | 18 | 4 | 22 |
Endometrioid | 0 | 1 | 1 |
Mixed | 1 | 0 | 1 |
Types of benign diseases | N | % | |
Benign ovarian lesions | 48 | 49.92 | |
Ovarian thecofibroma | 2 | 2.08 | |
Leiomyomata | 55 | 57.2 |